h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
ZSSYe001-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
ZSSYe001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
ZSSYe001-A (RRID:CVCL_YP14)
Cell line type
Human embryonic stem cell (hESC)
Similar lines
No similar lines found.
Last update
2nd March 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
Contact:
Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
Owner
Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
Distributors
Third Affiliated Hospital of Sun Yat-sen University (ZSSY)
External Databases
Cellosaurus
CVCL_YP14
BioSamples
SAMEA8325241
Wikidata
Q98136625
General Information
Publications
Xu C et al. Generation of a DAPK1 knockout first (conditional ready) human embryonic stem cell line (ZSSYe001-A) by CRISPR-Cas9 technology. Stem cell research. 2020 Mar;43:101693.
Zhang B. CRISPR/Cas gene therapy. Journal of cellular physiology. 2021 Apr;236(4):2459-2481.
Yang Xianguang et al. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment. Functional & Integrative Genomics. 2023-06-00.
* Is the cell line readily obtainable for third parties?
Yes
Research use:
allowed
Clinical use:
not allowed
Commercial use:
not allowed
Login to share your feedback, experiences or results with the research community.